Vir Biotechnology

Vir Lays Off 25% of Staff, Abandons Most Virus Work and Pivots to Cancer in Sanofi Deal
BioSpace
Fri, 08/2/24 - 11:31 am
Vir Biotechnology
layoffs
Sanofi
cancer
virology
Vir pressures Gilead with hepatitis D cocktail showing early efficacy in phase 2
Fierce Biotech
Wed, 06/5/24 - 11:01 am
Vir Biotechnology
hepatitis D
clinical trials
Gilead Sciences
How Vir found the one: CEO Marianne De Backer
Fierce Biotech
Fri, 04/19/24 - 11:31 am
Vir Biotechnology
Pharma CEOs
Marianne De Backer
GSK, Vir end flu drug alliance, removing key piece of $345M pact
Fierce Biotech
Fri, 02/23/24 - 10:30 am
GSK
Vir Biotechnology
Flu
monoclonal antibodies
Vir, in midst of restructuring, loses its chief medical officer
BioPharma Dive
Wed, 02/21/24 - 10:39 pm
Vir Biotechnology
restructuring
Vir goes Grinch, eliminating 75 posts and shuttering 2 US sites to slow erosion of $1.7B cash pile
Fierce Biotech
Thu, 12/14/23 - 09:41 am
Vir Biotechnology
layoffs
HIV Vaccine Trial of Vir Biotech’s New Candidate VIR-1388 Begins
Xtalks
Thu, 09/21/23 - 06:36 pm
Vir Biotechnology
clinical trials
HIV
VIR-1388
Vir antibody drug aimed at influenza A fails in clinical trial
Stat
Thu, 07/20/23 - 09:56 am
Vir Biotechnology
influenza A
clinical trials
VIR-2482
Vir Biotechnology awarded $10 million grant by Bill & Melinda Gates Foundation to develop HIV vaccine
Biopharma Reporter
Tue, 05/9/23 - 11:38 am
Vir Biotechnology
Gates Foundation
vaccines
HIV
GSK nixes next-gen COVID-19 antibody collaboration, leaving Vir to fly solo, seek new partners
Fierce Biotech
Tue, 02/14/23 - 11:02 am
GSK
Vir Biotechnology
COVID-19
vaccines
In post-Covid life, Vir looks to stomp out influenza in up to $1B BARDA contract that boosts GSK-allied mAb
Endpoints
Tue, 10/4/22 - 10:45 am
Vir Biotechnology
COVID-19
Flu
BARDA
federal contracts
Vir doses first subject in Phase II hepatitis D virus treatment trial
Clinical Trials Arena
Fri, 09/23/22 - 10:32 am
Vir Biotechnology
hepatitis D
VIR-2218
VIR-3434
clinical trials
FDA halts Vir, GSK antibody use in response to COVID subvariant's spread
BioPharma Dive
Wed, 04/6/22 - 12:28 pm
FDA
GSK
Vir Biotechnology
antibodies
COVID-19
Omicron BA.2
FDA cuts off use of GSK's Covid treatment in almost half of the US as BA.2 spreads
Endpoints
Mon, 04/4/22 - 10:21 am
FDA
GSK
Vir Biotechnology
monoclonal antibodies
COVID-19
Omicron BA.2
Officials limit an antibody therapy, saying it’s ineffective against BA.2 variant of Omicron
Stat
Sun, 03/27/22 - 04:00 pm
Vir Biotechnology
GSK
monoclonal antibodies
sotrovimab
COVID-19
Omicron BA.2
FDA
Big Pharma has skirted long Covid, but a pipeline of small biotechs are testing treatments for lingering symptoms
Endpoints
Sun, 03/27/22 - 03:58 pm
COVID-19
Long COVID
GSK
Vir Biotechnology
Humanigen
Pfizer
Roche
Atea Pharmaceuticals
With sotrovimab in the balance, Biogen vet reunites with George Scangos at Vir; First woman to chair PhRMA has more in store at Takeda
Endpoints
Fri, 02/11/22 - 10:11 am
Biogen
Vir Biotechnology
GSK
Johanna Friedl-Naderer
Takeda
PhRMA
GlaxoSmithKline rushes to accelerate COVID-19 antibody output amid omicron-driven demand
Fierce Pharma
Sat, 01/22/22 - 02:14 pm
GSK
Vir Biotechnology
COVID-19
antibodies
drug manufacturing
Samsung BioLogics
Vir expands partnership with Gates Foundation, adding $50M for HIV and malaria antibody research initiative
Endpoints
Sun, 01/16/22 - 03:50 am
Vir Biotechnology
vaccines
Gates Foundation
HIV
malaria
US pauses distribution of GSK/Vir's Covid mAb not due to Omicron, but greater supply of Eli Lilly mAbs
Endpoints
Wed, 12/15/21 - 10:42 am
GSK
Vir Biotechnology
Eli Lilly
monoclonal antibodies
COVID-19

Pages